glp-1 and sarcopenia therapy is reshaping metabolic care — as nutrition professionals, we need to be ready for it. 💉🥗 The questions are getting more complex: How do we adapt dietary protocols for Glucagon-like peptide-1 receptor agonists and

Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes

Emily Kirby oversees our weight loss medications so that you receive an FDA-approved product, the appropriate dosage, and personalized, ongoing care and support

No prospective cohort studies

Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism

Cardiovascular comorbidities among patients with psoriasis: A national register-based study in China

Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and -cell glucose responsiveness in VDF (fa/fa) Zucker rats